SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Martek Biosciences---- future biotech cash cow!

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Asymmetric who wrote (3)2/25/1996 6:05:00 PM
From: bill small   of 258
 
More Martek news

Peter, sorry I didn't get to edit post above but my power went out
before I got chance.

One more item about Martek is seldom mentioned but potentially a big
kicker. They plan to sell the Formulaid key ingredients as a vitamin
supplement. Prime customers are pregnant women, lactating women since
DHA ingredient is benifical. AlsoDHA lowers HDL/LDL ratio so is good
choice to use for lessening heart disease. Martek will go after this
market as Formaulaid sales to formula companies takes off.

The work with Merck is a real potential but developements from the
colloboration will likely have to go through years of trails. But
meanwhile the Formulaid will give huge earnings and give company
$ to explore many other products.

best..........Bill
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext